|
|
Brian L. Bray
Senior Vice President/Kainos Medicine USA, Inc.
1978 – 1982 Loras College, B.S. Chemistry, magna cum laude
1982 – 1987 University of Washington, Ph.D. Organic Chemistry
1987 – 1989 Postdoctoral Research, Syntex Research, Palo Alto, CA.
1989 – 1990 Senior Scientist, Chemical Development Division, Glaxo Inc.
1990 – 1992 Research Investigator I, Chemical Development Division, Glaxo Inc.
1992 – 1997 Research Investigator II, Chemical Development Division, GlaxoWellcome
1997 – 1998 Principle Investigator, Trimeris, Inc.
1998 – 2001 Director, Process Research and Development, Trimeris, Inc.
2001 – 2003 Senior Director, Process Research and Development, Trimeris, Inc.
2003 – Vice President, Development, Trimeris, Inc.
Leadership Experience
1997 – 2003 Process Research and Development Department, Trimeris, Inc.
1995 – 1997 Laboratory Head & Team Leader, Multifunctional Development Team
2003 – Vice President, Development, Trimeris. Inc: Chemical Research, Process Chemistry, Analytical Sciences, Pharmaceutical Research, Peptide Synthesis, DMPK
Honors/Awards
American Chemical Society’s 53rd Southeastern Regional Industrial Innovation Award (2001)
Chevron Fellowship Recipient, University of Washington
Presidential Scholarship, Loras College
Delta Epsilon Sigma honor society, Loras College
Presentations
2000 26th European Peptide Symposium, “Large Scale Chemical Synthesis of T-20, a Thirty-six Amino Acid Peptide”
2001 The American Chemical Society’s 53rd Southeastern Regional Industrial Innovation Awards Symposium, “Large Scale Chemical Synthesis of T-20, A Thirty-six Amino Acid Peptide. The First Member of a Class of Anti-Retroviral Agents that Inhibit HIV-1 Membrane Fusion”
2002 NC State Department of Chemistry, “Development of Peptides (Macromolecules) as Pharmaceuticals” Organic Division Seminars
Tides 2002, “Grams to Tons, a T-20 Development Update
2003 Development and Manufacturing Needs in Health Care Industries for the 21st Century, “Large-Scale Manufacture of Peptide Therapeutics by Chemical Synthesis: The Myths and the Facts” University of Michigan Colleges of Engineering and Pharmacy
2004 University of Wisconsin School of Pharmacy, “Large Scale Manufacture of Peptide Therapeutics by Chemical Synthesis: The Fuzeon Process
Duke University, Fuqua School of Business, “Large Scale Manufacture of Peptide Therapeutics by Chemical Synthesis: The Fuzeon Process”
2007 The Roche Colorado Peptide Symposium (RCCPS2007), “1144, the Next Generation Fusion Inhibitor from Trimeris”, September 26th, 2007. | |
|
|
Thomas X. Neenan
Vice President/Trine Pharmaceuticals, Inc.
1975 – 1979 National University of Ireland, B. Sc.
1979 – 1985 Pennsylvania State University, Ph.D. Chemistry
1985 – 1987 Harvard University, Post-doctoral Fellowship, Chemistry
1988 – 1995 Member, Technical Staff and Principal Investigator, AT&T Bell Laboratories
1995 – 1997 Director, Infectious Disease Research, GelTex Pharmaceuticals
1997 – 2002 Director, Senior Director & Vice President, New Technologies and New Ventures, GelTex Pharmaceuticals (acquired by Genzyme, 2000)
2002 – 2004 Vice President, Business Operations, Genzyme Drug Discovery & Development
2004 – Founding Investor, Executive Vice President & Interim CEO, Warwick Effect Polymers Coventry, UK
Vice President, Business Development, Trine Pharmceuticals
Founder & CEO, Adhera Technologies | |
|
|
Doo-Seop Kim
Ex-Senior Investigator/Merck & Co., Inc.
1979 Sungkyunkwan University, B.S. Chemistry
1981 Seoul National University, M.S. Chemistry
1988 University of Pittsburgh, Ph.D. Chemistry
1988 – 1990 Post doctoral Research Fellow, Columbia University
1990 – 2009 Senior Investigator, Merck & Co., Inc.
Achievement
Discovery of Type 2 Diabetes Medication Januvia
Awards
Recipient, Thomas Alva Edison Patent Award (2007)
Recipient, Merck Division Staff Award (2007) | |
|
|
Young- Choon Moon
Director/PTC Therapeutics, Inc.
1976 – 1980 Sogang University, B.S. Chemistry & Trade
1980 – 1982 Korea Advanced Institute of Science & Technology, M.S. Organic Chemistry
1985 – 1990 University of Illinois, Urbana-Champaign, Ph.D. Organic Chemistry
1990 – 1993 Harvard University, Postdoctoral Research Associate
1996 – 1997 University of California at Berkeley, Visiting Scholar
2002 – 2003 Group Leader, Combinatorial Chemistry, PTC Therapeutics, Inc.
2003 – 2006 Group Leader, Analytical Chemistry, PTC Therapeutics, Inc.
2002 – Associate Director of Chemistry, PTC Therapeutics, Inc.
2007 – Director of Chemistry, PTC Therapeutics, Inc.
Key Accomplishments
PTC124: Co-inventor of PTC124, Developer of Process Chemistry
Human Clinical Trial Ph IIb/III in Duchenne Muscular Dystrophy and Cystic Fibrosis Research Currently in Process
PTC299: Project Leader and Inventor of PTC124, Developer of Process Chemistry
Human Clinical Trial Ph Ib/III in Metastatic Breast Cancer, Advanced Cancer, and HIV-Related Kaposi's Sarcoma Research Currently in Process
Awards
Excellence Prize, Sogang University Research Paper (1978)
Encouragement Prize, Seoul National University Research Presentation.(1978)
University of Illinois R. C. Fuson Travel Award (1988)
SBR/CKD Bioscience Award, 14th Annual Meeting of Society of Biomedical Research (2004)
KASBP-Daewoong Year of Scientist Award, 8th Annual KASBP Symposium (2008)
Memberships
1979 – 1980 Alpha Sigma Nu Honor Society, Sogang University,
1980 – Alpha Sigma Nu Honor Society, Sogang Alumni
1985 – American Chemical Society, Organic Chemistry and Medicinal Chemistry Division
1998 – Society of Biomedical Research
2002 – Korean-American Society in Biotech & Pharmaceutical Industries (KASBP)
2003 – Korean-American Scientists and Engineers Association (KSEA)
American Association for Cancer Research
Patents
1. EP1581526B1: BENZISOXAZOLE DERIVATIVES USEFUL AS INHIBITORS OF PROTEIN KINASES LEDEBOER, Mark; DAVIES, Robert, J.; MESSERSMITH, David; MOON, Young-Choon; MULLICAN, Michael, D., VERTEX PHARMACEUTICALS INCORPORATED, 2009-03-11 / 2003-12-17
2. EP1603886B1: 4-SUBSTITUTED-5-CYANO-1H-PYRIMIDIN-6-(THI)ONES AS GSK-3 INHIBITORS, MOON, Young-Choon, VERTEX PHARMACEUTICALS INCORPORATED, 2009-02-18 / 2004-03-12
3. US20090042866A1: Tetrahydrocarbazoles as Active Agents for Inhibiting VEGF Production by Translational Control, Lennox, William; Qi, Hongyan; Lee, Duck-Hyung; Choi, Soongyu; Moon, Young-Choon; PTC THERAPEUTICS, INC. 2009-02-12 / 2005-11-23
4. US7456190: Compositions useful as protein kinase inhibitors, Maltais, Francois;
Aronov, Alex; Hale, Michael R.; Moon, Young-Choon, Vertex Pharmaceuticals Incorporated, 2008-11-25 / 2004-03-11
5. WO08130370A1: HYDROXYLATED 1,2,4-OXADIAZOLE BENZOIC ACID COMPOUNDS, COMPOSITIONS THEREOF AND THE USE FOR NONSENSE SUPPRESSION, ALMSTEAD, Neil, G.; HWANG, Peter, Seongwoo; MOON, Young-Choon; WELCH, Ellen, M. PTC THERAPEUTICS, INC. 2008-10-30 / 2007-09-24 | |
|
|
Jin-Keon James Pai
Executive Vice President/Choongwae Pharma Corporation
1974 Yonsei University, B.S. Biochemistry
1982 University of Wisconsin-Madison, School of Pharmacy, Ph.D. Pharmaceutical Biochemistry
1982 – 1986 Research Associate, McArdle Laboratory for Cancer Research, University of Wisconsin-Madison
1986 – 1988 Research Scientist, Department of Allergy & Inflammation, Schering-Plough Research Institute
1988 – 1991 Senior Scientist, Department of Molecular Pharmacology
1991 – 1994 Associate Principal Scientist
1994 – 1995 Principal Scientist, Department of Tumor Biology, Schering-Plough Research Institute
2001 – 2008 Senior Principal Scientist, Department of Tumor Biology, Schering-Plough Research Institute
2008 – Executive Vice President, Choongwae Pharma Corporation
Chair of ChoongWae Central Research Institute
Korean-American Scientists and Engineers Association (KSEA) Experience
Councilor, KASBP (Korean-American Society in Biotech and Pharmaceuticals) & KSEA-NJ Chapter
Group F (Biotech) Councilor, KSEA HQ
Auditor of KSEA-NY Metro | |
|
|
Jeong-Chan Ra
CEO/RNL Bio Co., Ltd.
1982 – 1986 Seoul National University, College of Veterinary Medicine
B.S. Veterinary Medicine
1992 – 1994 Seoul National University, Graduate School of Medicine
M.S. Veterinary Medicine
2005 – 2008 Cheju National University Graduate School
Ph.D. Veterinary Medicine
1987 – 1994 Head, Marketing team, Bayer Group Korea
1994 – 2000 Head, Animal Medicine Team, LG Chemistry
2005 – Chairman, President & CEO, RNL Bio Co., Ltd.
2006 – Chairman, President & CEO, RNL Biostar Inc. USA.
2009 – Chairman of Director, Bethesda Samsung Hospital
Achievements
Leading new product development, Marketing, global business development of LG Chemistry
Leading Global networking of LG animal medicine
New product development : Accent, Euvectin, Biogus, sweetener
Strategic alliance with multinational corporation: Shering Plough(USA), Alphama(USA), Virbac(France), Delaval(Sweden)
Awards
LG research and developing grant (1998, 2000)
Venture Business Grand Prize, Prime Minister Prize (2003)
Korean Technology Awards Grand Prize (2007)
Patent
2003 Viable lactobacilli and method for the treatment and protection of fowl typhoid
Antiviral composition using natural product
2004 Composition for protecting and treating viral diseases comprising oldenlandia diffusa and ganoderma lucidum extracts
Phytoestrogenic composition comprising an extract of chinese licorice root or isoliquiritin
Composition for preventing or treating obesity comprising an extract of rubus coreanus miquel as an active ingredient
Functional composition comprising oldenlandia diffusa and ganoderma lucidum extracts
2005 Food for preventing breast cancer containing anisoliquiritin
Composition for promoting growth of animal comprising extracts of artemisia capillaris thunberg.,acanthopanax and garlic and feed composition for promoting growth comprising the composition
2006 Method for preparing a domestic fowl having enhancedoleic acid using feed composition comprising extractsof artemisia capillaris thunberg, garlic andacanthopanax | |
|
|
Sun-Young Kim
CEO/ViroMed Co. Ltd.
1978 Seoul National University, B.S. Microbiology
1982 MIT, M.S. Biochemical Engineering
1984 Harvard University, M.A. Microbiology and Molecular Genetics
1986 Oxford University Ph.D. Molecular Genetics
1987 – 1989 Postdoctoral Fellow, Whitehead Institute for Biomedical Research, Department of Biology, MIT
1990 – 1992 Assistant Professor of Medicine (Virology), Harvard University
1992 – 2001 Assistant Professor and Associate Professor, Seoul National University
2006 – 2008 President, Korea Society of Gene Therapy
2009 Professor, Seoul National University
Member of Editorial Board, Journal of Gene Medicine
CEO, ViroMed Co. Ltd. (Korea) | |
|
|
Gio-Bin Lim
General Director/Next Generation Growth Engine, Korea Biotech R&D Group
1978 B.S., Chemical Engineering, Yonsei University
1982 M.S., Chemical Engineering, Yonsei University
1989 Ph.D., Chemical Engineering, University of Pittsburgh
1989 – 1990 Post Doc., Food Science, Cornell University
1990 – 1991 Post Doc., Chemical Engineering, Princeton University
1991 – Professor, Chemical Engineering, University of Suwon
2005 – 2006 Project Manager (PM), Korea Research Foundation (KRF), Ministry of Education, Science and Technology (MEST)
2006 – 2007 Chief Project Manager and PM in Biotechnology, Korea Institute of Industrial Technology Evaluation and Planning (ITEP), Ministry of Knowledge Economy (MKE)
2007 – General Director, Next Generation Growth Engine, Korea Biotech R&D Group (KBRDG), MEST
2009 – President, Korea Drug Researcher Association, MEST
2009 – Chief Vice President, Korean Society of Biotechnology and Bioengineering (KSBB; President in 2010)
Award
2005 The 15th Excellent Science and Technology Research Award, Korean Federation of Sci. and Tech. Societies (KOFST), MEST | |
|
|
Sung-Soo Kim
Vice President/Korea Research Institute of Chemical Technology
1984 B.S. Chemistry & Education, Seoul National University
1988 Ph.D. Organic Chemistry, Korea Advanced Institute of Science and Technology
1988 – 1990 Postdoctoral Fellow, Department of Chemistry, Harvard University, MA, USA
2003 – 2004 Visiting Scientist, PTC Therapeutics, South Plainfield, NJ, USA
1990 – 1997 Senior Research Scientist, Korea Research Institute of Chemical Technology
1997 – Principal Research Scientist, Korea Research Institute of Chemical Technology
1999 – 2002 Secretary of the Division of Medicinal Chemistry, Korea Chemical Society
2006 – 2007 Director, Bio-Organic Science Division, Korea Research Institute of Chemical Technology
2007 – 2008 Coordinator for Life Science & Oceanology, Ministry of Science & Technology
2008 – Vice President, Korea Research Institute of Chemical Technology | |
|
|
Dae-Kyong Kim
Dean, College of Pharmacy/Chung-Ang University
1976 – 1983 Seoul National University, B.S. Pharmaceutical Sciences
1984 – 1986 Seoul National University, M.S. Pharmaceutical Sciences
1986 – 1990 University of Tokyo, Ph.D. Pharmaceutical Sciences for Life
1991 – 1994 Research Associate, MGH Institute, Harvard University School of Medicine
1992 – 1994 Research Fellow, Paul Dudley Awards American Heart Association
1994 – Assistant Professor, Associate Professor & Professor, Chung-Ang University
2006 – Consultant, Division of BioNano Technology for Strategic Industry, Ministry of Knowledge Economy Korea
2008 – Member, Steering Committee of National Science & Technology Council,
2009 – Vice President, Pharmaceutical Society of Korea
Vice President, Korean Society of Food Hygiene and Safety
Vice President, KHUPO
Dean, College of Pharmacy, Graduate School of Drug & Food Administration, Chung-Ang University, Seoul, Korea
RESEARCH INTERESTS
1. Identification of new drug targets based on signal transduction study
2. Development of protein-based new therapeutics in various diseases
3. Identification of new biomarkers through proteomic analysis
4. Pharmacological and toxicological tests for new drug development | |
|
|
Sung-Eun Yoo
Director, 21c Frontier Research Program/Korea Research Institute of Chemical Technology
1968 – 1972 Seoul National University, B.S. Chemistry
1972 – 1974 Seoul National University, M.S. Organic Chemistry
1974 – 1977 Yale University, Ph.D. Organic Chemistry
1977 – 1979 Harvard University, Post-Doc. Organic Chemistry
1972 – 1974 Teaching Assistant, Seoul National University Graduate School
1974 – 1977 Teaching Assistant, Yale University
1979 – 1987 Senior Research Chemist, E.I. Dupont Co.
1987 – Director, Bio-Organic Science Division, Korea Research Institute of Chemical Technology
2001 – Director, Center for Biological Modulators
2009 – Director, 21c Frontier Research Program (Ministry of Education, Science & Technology, Korea)
Research Achievements
Discovery of KR-31378 for Glaucoma (in Phase II in UK)
Discovery of PET Ligand (in Phase II in USA)
Discovery of KR-33028 for Ischemic Diseases (preclinical study in progress in Korea)
Research Interests
New Drug Discovery- Medicinal Chemistry
Combinatorial Chemistry
Computer Modeling
QSAR
Organic Chemistry- Organic Synthesis
Methodology
Patents & Publications
Inventor in 79 patents
Author in 208 publications | |
|
|
Hyi-Jeong Ji
Vice president/LG Life Sciences, Ltd.
1982 B.Sc., Biochemistry, Yonsei University, Seoul, Korea
1984 M.Sc., Biochemistry, Yonsei University, Seoul, Korea
1994 Ph.D., Biochemistry, Biology, Purdue University, Indiana, USA
Research & Development Experience
1984 – 1985 Instructor and Research Assistant, Dept. of Biochemistry, School of Medicine, Korea University, Seoul, Korea
1994 – 1996 Post-doctoral Research Associate, Dept. of Biology, Purdue University, Indiana
1996 Join in LG Chem. R&D, Biotech Institute (Research Scientist)
Vaccine / Biopharmaceutical Research & Development
2001 Principal Scientist, Biotech, Life Sciences R&D, LG Chem., Ltd.
2002 General Manager, RA2, Pharmaceutical Division, LG Life Sciences, Ltd.
Vaccine/Biopharmaceutical development/product registration
2004 Project Leader, Sr-hGH/hGH Pjt
2006 Vice president, Product development, Pharmaceutical Division, LG Life Sciences, Ltd. (Valtropin EMEA approval)
2007 – Vice president, (Sr-hGH/hGH) Product development P/L
Present (Valtropin US FDA approval) | |
|
|
Gang-Lip Kim
Director General, Bureau of Health Industry Policy/Ministry for Health, Welfare and Family Affairs
1984 – 1989 BA Department of Sociology, Yonsei University, Seoul, Korea
1995 – 1997 MA Chicago University, Chicago city, Illinois, USA
PROFESSIONAL EXPERIENCE
1990 be chosen at the National Competitive Recruitment Exam of Executive Deputy Director
1992 – 1994 Deputy Director, Ministry secretariate, Ministry for Health and Welfare
1998 – 2001 Deputy Director, Division of Health Insurance Policy
2001 – 2002 Deputy Director, Division of National Pension Policy
2002 – 2002 Director, Division of Health Insurance Benefits
2003 – 2006 Korea Government's Representative at ESCAP (Economic and Social Commission for Asia and Pacific)
2006 – 2007 Director, Division of Policy for Persons with Disabilities
Director, Division of Rehabilitation Support for Persons with Disabilities
2007 – 2009 Director, Division of Health Care Policy
Current Director General, Bureau of Health Industry Policy | |
|
|
Kyung Huh
Director General, Bureau of Emerging Industries/Ministry of Knowledge Economy
1975 – 1979 B.S. Mechanical Design, Pusan National University
1979 – 1981 M.A. School of Aeronautics, KAIST
1997 – 1999 M.A. School of Public Administration, Wisconsin University, USA
Professional Experience
2003 – 2004 Director, Industry & Environment Cooperation Division, Ministry of Commerce, Industry and Energy
2004 – 2005 Director, Technology for Resources Division, MOCIE
2005 – 2005 Director, Energy Efficiency Division, MOCIE
2005 – 2006 Director, Resources Policy Division, MOCIE
2006 – 2006 Director General, Bureau of Technology & Standards, MOCIE
2006 – 2007 Expert advisor, SK Research Institute for SUPEX Management
2008 – 2009 Director General, Bureau of Technology & Standards Policy, Korean Agency for Technology & Standards
2009 – Director General, Bureau of Emerging Industries, Ministry of Knowledge Economy | |
|
|
Hang-Sik Park
Director General, Basic Research Policy Bureau/Ministry of Science & Technology
Boseong High School, Korea
Economics, Yonsei University, Korea
Industrial Development, Sussex University, UK
Public Administration, Dongguk University, Ph.D, Korea
1982 passed "Senior Administrative Service Enterance Exam"
1993 Assistant Secretary to the President for Economy
1996 Director of CSTP in OECD Headquarter
2002 Director General, Atomic Energy Bureau, MOST
2005 Director General, Science & Technology Infrastructure Bureau, MOST
2006 Secretary General, Presidential Advisory Council on Science and Technology
2007 Deputy Minister for R&D Coordination, Ministry of Science & Technology
2008 Director General, Science & Technology Planning Bureau
2009 Director General, Basic Research Policy Bureau | |
|
